Label: LINGLONGJIUHUO LINGLONG MOXIBUSTION WORMWOOD MOXIBUSTION PATCH- herbal moxibustion tape

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated October 15, 2022

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    butylene glycol 20% w/w

  • Inactive ingredient

    water

    hydroxyethylcellulose

    polyethylene glycol 300000

    phenoxyethanol

    chlorphenesin

  • Purpose

    It is a heat disposable paster incorporating chemicals that provides heat therapy for body.

  • When using

    Conditioning neck, back, hands and feet and other rheumatism pain and spleen and stomach caused by cold injury, deficiency diarrhea and other conditions.

  • Do not use

    Pregnant women, diabetics, skin ulcers, and acute bleeding disorders are prohibited.

  • Stop use

    If irritation or discomfort occurs, discontinue the use and consult a physician.

  • Ask doctor

    If irritation or discomfort occurs, discontinue the use and consult a physician.

  • Ask doctor/pharmacist

    Ask doctor/pharmacist when you current use other drugs.

  • Keep out of reach of children

    Keep out of reach of children and away from eyes and ears.

  • Questions

    Please contact with us at the phone number on the package when you have any questions.

  • Pregnancy or breast feeding

    Pregnant or breast feeding women shall follow doctor advice.

  • Indications & usage

    Pain relief, hot release, warming uterus, hemostatic, can be used to improve the conditioning neck, back, hands and feet and other rheumatism pain and spleen and stomach caused by cold injury, deficiency diarrhea and other conditions.

  • Dosage & administration

    1 piece at a time; once a day.

  • Dosage forms & strengths

    Its dosage form is patch.

    1 piece at a time; once a day.

    The active ingredient strength is 20% w/w.

  • Warnings

    [Warnings] This product is a disposable product for external use and cannot be taken orally. Keep out of reach of children.

    [Contraindications] Pregnant women, diabetics, skin ulcers, and acute bleeding disorders are prohibited.

  • Package label. Principal display panel

    011120

  • INGREDIENTS AND APPEARANCE
    LINGLONGJIUHUO LINGLONG MOXIBUSTION WORMWOOD MOXIBUSTION PATCH 
    herbal moxibustion tape
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73510-526
    Route of AdministrationCUTANEOUS, EXTRACORPOREAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA) (BUTYLENE GLYCOL - UNII:3XUS85K0RA) BUTYLENE GLYCOL0.2 g  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%) (UNII: 12VCE9HR9E)  
    WATER (UNII: 059QF0KO0R)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    POLYETHYLENE GLYCOL 300000 (UNII: 4QIB4U4CQR)  
    CHLORPHENESIN (UNII: I670DAL4SZ)  
    Product Characteristics
    ColorbrownScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73510-526-201 in 1 BOX10/17/2022
    1NDC:73510-526-1110 in 1 BAG
    1NDC:73510-526-011 g in 1 PACKET; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other10/17/2022
    Labeler - Shanghai Jingqin Biological Technology Co., Ltd. (554428240)
    Registrant - Shanghai Jingqin Biological Technology Co., Ltd. (554428240)
    Establishment
    NameAddressID/FEIBusiness Operations
    Hubei Lishizhen Modern Biological Medicine Group Co.,Ltd.421166905manufacture(73510-526)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!